journal article·2023-05-24

Composite Hydrogel Conduit Incorporated with Platelet-Rich Plasma Improved the Regenerative Microenvironment for Peripheral Nerve Repair

Qi Dong, Xindi Yang, Xiao Liang, Jing Liu, Binyi Wang, Yanteng Zhao, Céline Huselstein, Xiaolin Feng, Zan Tong, Yun Chen

ACS Applied Materials & Interfaces· Volume 15· Issue 20
Publisher page

Abstract

Peripheral nerve regeneration and functional recovery remain major challenges in clinical practice. Nerve guidance conduits (NGCs) which can regulate the regenerative microenvironment are beneficial for peripheral nerve repair. Platelet-rich plasma (PRP) can secrete multiple growth factors to regulate the regenerative microenvironment. However, current administration methods of PRP are rapidly activated followed by the burst release of growth factors, causing low therapeutic efficiency in vivo . To overcome these disadvantages, a composite nerve conduit was fabricated by incorporating PRP into a gelatin methacrylate (GelMA) and sodium alginate (SA) hydrogel. The GelMA/SA-3/PRP-20 NGCs possess optimal mechanical properties, degradation rate, and superior biological performance. Importantly, GelMA/SA-3/PRP-20 NGCs achieved the sustained release of two major growth factors (VEGF-A, PDGF-BB) from PRP. Moreover, the GelMA/SA-3/PRP-20 NGCs significantly promoted the migration of Schwann cells and the neovascularization of endothelial cells in vitro . While bridging 10 mm rat sciatic nerve defects, the GelMA/SA-3/PRP-20 NGCs promoted axonal regeneration and functional recovery of peripheral nerves. Therefore, the GelMA/SA-3/PRP-20 NGCs could regulate the regenerative microenvironment by sustained release of growth factors from PRP and shed new light on the clinical application of PRP in peripheral nerve repair.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nerve injury and regeneration · Wound Healing and Treatments · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering and Hubei Province Key Laboratory of Allergy and Immune Related Disease, TaiKang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan 430071, China

Hubei Provincial Key Laboratory of Developmentally Originated Disease, TaiKang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan 430071, China

Department of Blood Transfusion, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

UMR 7365 CNRS, Medical School, University of Lorraine, 54505 Nancy, France

Hospital of Wuhan Zijing, Wuhan 430071, China

Funding

Wuhan University · National Natural Science Foundation of China · Zhongnan Hospital of Wuhan University

References (54)

Show source-provided references
1. 10.1038/s41593-020-0689-410.1038/s41593-020-0689-4 ↗
2. 10.1002/glia.2389210.1002/glia.23892 ↗
3. 10.1016/j.biomaterials.2014.04.06410.1016/j.biomaterials.2014.04.064 ↗
4. 10.1016/j.actbio.2019.06.05410.1016/j.actbio.2019.06.054 ↗
5. 10.1016/j.pneurobio.2010.11.00210.1016/j.pneurobio.2010.11.002 ↗
6. 10.1016/j.cell.2015.07.02110.1016/j.cell.2015.07.021 ↗
7. 10.1016/j.msec.2017.08.03010.1016/j.msec.2017.08.030 ↗
8. 10.1016/j.jconrel.2011.11.03610.1016/j.jconrel.2011.11.036 ↗
9. 10.1021/acsnano.0c0357010.1021/acsnano.0c03570 ↗
10. 10.1016/j.neuroscience.2013.03.05010.1016/j.neuroscience.2013.03.050 ↗
11. 10.1016/j.biomaterials.2011.10.03710.1016/j.biomaterials.2011.10.037 ↗
12. 10.1016/j.bioactmat.2021.03.02010.1016/j.bioactmat.2021.03.020 ↗
13. 10.3389/fncel.2020.0023710.3389/fncel.2020.00237 ↗
14. 10.1046/j.1471-4159.1997.68031150.x10.1046/j.1471-4159.1997.68031150.x ↗
15. 10.4103/1735-3327.18218110.4103/1735-3327.182181 ↗
16. 10.1016/j.ecl.2012.04.02010.1016/j.ecl.2012.04.020 ↗
17. 10.1111/jcpe.1319310.1111/jcpe.13193 ↗
18. 10.1038/s41581-018-0015-510.1038/s41581-018-0015-5 ↗
19. 10.1038/boneres.2016.3610.1038/boneres.2016.36 ↗
20. 10.1126/science.112384210.1126/science.1123842 ↗
21. 10.1007/s00395-008-0721-410.1007/s00395-008-0721-4 ↗
22. 10.3389/fbioe.2022.80824810.3389/fbioe.2022.808248 ↗
23. 10.4103/1673-5374.13758710.4103/1673-5374.137587 ↗
24. 10.1002/jbm.a.3225410.1002/jbm.a.32254 ↗
25. 10.1016/j.apmt.2019.05.01410.1016/j.apmt.2019.05.014 ↗
26. 10.22203/ecm.v033a0510.22203/ecm.v033a05 ↗
27. 10.1002/adfm.20200925810.1002/adfm.202009258 ↗
28. 10.3390/gels804021610.3390/gels8040216 ↗
29. 10.1016/j.biomaterials.2015.08.04510.1016/j.biomaterials.2015.08.045 ↗
30. 10.1002/adfm.20200375910.1002/adfm.202003759 ↗
31. 10.1016/j.jconrel.2019.05.00110.1016/j.jconrel.2019.05.001 ↗
32. 10.1088/1741-2552/ab411410.1088/1741-2552/ab4114 ↗
33. 10.1002/adfm.20200427210.1002/adfm.202004272 ↗
34. 10.1093/bmb/ldu00710.1093/bmb/ldu007 ↗
35. 10.1021/acschemneuro.9b0020310.1021/acschemneuro.9b00203 ↗
36. 10.1002/pi.437210.1002/pi.4372 ↗
37. Everts P. A. · J. Extra-Corpor. Technol. · 2006 · 38 · 17410.1051/ject/200638174 ↗
38. 10.1177/036354651667447510.1177/0363546516674475 ↗
39. 10.1038/s41467-019-10004-710.1038/s41467-019-10004-7 ↗
40. 10.1016/j.bioactmat.2021.06.02010.1016/j.bioactmat.2021.06.020 ↗
41. 10.1016/j.mvr.2019.10395910.1016/j.mvr.2019.103959 ↗
42. 10.1007/s13770-021-00383-810.1007/s13770-021-00383-8 ↗
43. 10.1002/advs.20180207710.1002/advs.201802077 ↗
44. 10.1039/d1bm00470k10.1039/d1bm00470k ↗
45. 10.1002/adfm.20210246510.1002/adfm.202102465 ↗
46. 10.1016/j.expneurol.2018.08.01410.1016/j.expneurol.2018.08.014 ↗
47. 10.1097/00006534-199612000-0002310.1097/00006534-199612000-00023 ↗
48. 10.1016/j.actbio.2021.07.02610.1016/j.actbio.2021.07.026 ↗
49. 10.1016/j.carbpol.2017.05.00610.1016/j.carbpol.2017.05.006 ↗
50. 10.1016/j.bioactmat.2021.03.03410.1016/j.bioactmat.2021.03.034 ↗
51. 10.1002/term.175610.1002/term.1756 ↗
52. 10.1002/adma.20210417510.1002/adma.202104175 ↗
53. 10.1002/mabi.20210039710.1002/mabi.202100397 ↗
54. 10.1016/j.biomaterials.2021.12126910.1016/j.biomaterials.2021.121269 ↗